Cc1ccc(Nc2ccc(N3CCN(C(=O)c4cccc([N+](=O)[O-])c4)CC3)nn2)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?